78.8%
rimiducidIL-2CLDN6-specificCLDN6solid tumorsblood cancers
… signal 1 booster construct after 7 days of treatment -/+100 nM rimiducid in the presence of IL-2. (B) Expansion of T cells expressing th…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CLDN6 ×
CLDN6
This drug is selected. Its supporting articles are shown below.